Seismic Therapeutic Launches with $101 Million Series A Financing to Usher in a New Era of Immunology Drug Development Integrating Machine Learning
Engitix Nets $54M for Human Extracellular Matrix Drug Targets
Twice Rejected Diabetes Drug/Device Product Gets New Chance at Startup i2o
Lucy Therapeutics Expands Cutting-Edge Medical Research Program
Satellite Bio lifts off with $110M to fuel development of its implantable tissue therapies
Gilead joins a lineup of Big Pharma partners betting big on TriNKETs, with a $300M cash ante to get started on a 5T4
Amgen-backed Kernal Biologics pops off with $25M for mRNA platform
Nanopath is looking to drastically change medical diagnostics
PanTher Therapeutics Awarded $14.2M from CPRIT to Advance Targeted, Localized and Sustained Cancer Treatment
AstraZeneca to acquire gene editing biotech LogicBio
